08:30 AM EST, 02/10/2025 (MT Newswires) -- MediPharm Labs ( MEDIF ) on Monday said it has terminated its agreement to sell its Napanee facility in Ontario to Kensana Health because the buyer did not meet the required conditions.

MediPharm ( MEDIF ), which will retain certain deposits received from Kensana Health, said operations at the Napanee Facility, are expected to continue without disruption.

"Growing our profitable international revenue was a critical element of our success in 2024. We will continue to use the Napanee Facility to capitalize on international opportunities in 2025," said David Pidduck, CEO of MediPharm Labs ( MEDIF ).